T1	SNP 21 31	rs13281615
T2	Entity 57 61	PVT1
T3	Patho_physiology 77 95	cell proliferation
E1	Patho_physiology:T3 Theme:T4 Agent:T1
T4	Cancer 99 112	breast cancer
T5	Association 40 51	association
E2	Association:T5 bc:T4 snp_int:T1
T6	Gene_Regulation 62 72	expression
E3	Gene_Regulation:T6 Theme:T2 Agent:T1
T7	SNP 287 297	rs13281615
T8	Entity 271 275	8q24
R1	SNP_location Arg1:T7 Arg2:T8	
T9	Entity 382 393	gene desert
R2	SNP_location Arg1:T7 Arg2:T9	
R3	Equiv Arg1:T7 Arg2:T1	
A1	SNP_Type T7 Non-Coding
T10	SNP 221 233	several SNPs
T11	Entity 145 149	8q24
R4	SNP_location Arg1:T10 Arg2:T11	
T12	Cancer 202 215	breast cancer
T13	Association 330 341	association
E4	Association:T13 snp_int:T10
R5	Equiv Arg1:E4 Arg2:T12	
R6	Member Arg1:T10 Arg2:T7	
R7	SNP_location Arg1:T10 Arg2:T9	
A2	SNP_Type T10 Non-Coding
T14	Patho_physiology 433 444	development
E5	Patho_physiology:T14 Theme:T15 Agent:T10
T15	Entity 426 432	cancer
T16	Spec 445 469	remain to be illustrated
R8	Speculation_marker Arg1:E5 Arg2:T16	
T17	SNP 480 499	several of the SNPs
R9	Member Arg1:T10 Arg2:T17	
T18	Spec 500 509	appear to
T19	Gene_Regulation 510 529	influence the genes
E6	Gene_Regulation:T19 Agent:T17
R10	Speculation_marker Arg1:E6 Arg2:T18	
T20	Entity 584 635	v-myc avian myelocytomatosis viral oncogene homolog
T21	Entity 637 640	MYC
R11	Equiv Arg1:T21 Arg2:T20	
R12	Member Arg1:E6 Arg2:T21	
T22	Entity 669 705	plasmacytoma variant translocation 1
T23	Entity 707 711	PVT1
R13	Equiv Arg1:T23 Arg2:T22	
R14	Member Arg1:E6 Arg2:T23	
T24	Spec 820 829	potential
T25	SNP 801 811	rs13281615
T26	Association 830 834	role
E7	Association:T26 snp_int:T25 bc:T27
R15	Speculation_marker Arg1:E7 Arg2:T24	
T27	Cancer 838 851	breast cancer
T28	Entity 893 906	Chinese women
R16	Population_assignment Arg1:T25 Arg2:T28	
T29	Association 957 968	association
E8	Association:T29 bc:T32 snp_int:T31
T30	Entity 976 978	GG
A3	SNP_Type T25 Non-Coding
R17	SNP_location Arg1:T25 Arg2:T11	
T31	SNP 991 1001	rs13281615
R18	Genotype Arg1:T31 Arg2:T30	
T32	Cancer 1007 1020	breast cancer
A4	SNP_Type T31 Non-Coding
R19	SNP_location Arg1:T31 Arg2:T11	
R20	Population_assignment Arg1:T31 Arg2:T28	
T33	Level 1066 1079	significantly
T34	Association 1080 1090	associated
E9	Association:T34 snp_int:T31 bc:T35
A5	Level E9 High
R21	Level_marker Arg1:E9 Arg2:T33	
T35	Cancer 1096 1113;1119 1129	estrogen receptor positivity
A6	Cancer_Type T35 ER+
T36	Entity 1096 1113	estrogen receptor
T37	Effect_Type 1119 1129	positivity
T38	Organic_inorganic_molecules_affected 1080 1090	associated
E10	Organic_inorganic_molecules_affected:T38 Theme:T36 Agent:T31
R22	Effect_type_marker Arg1:E10 Arg2:T37	
A7	Effect_Type E10 Increase
T39	Other_effect 1138 1149	tumor grade
E11	Other_effect:T39 Agent:T31
T40	Level 1154 1160	higher
T41	Patho_physiology 1161 1180	proliferation index
E12	Patho_physiology:T41 Agent:T31
R23	Level_marker Arg1:E12 Arg2:T40	
T42	Entity 1342 1345	Gâ†’A
T43	Effect_Type 1369 1377	decrease
T44	Entity 1205 1222	somatic mutations
T45	SNP 1244 1252	this SNP
R24	Genotype Arg1:T45 Arg2:T44	
R25	Member Arg1:T44 Arg2:T42	
T46	Other_effect 1369 1377	decrease
E13	Other_effect:T46 Theme:T47 Agent:T45
T47	Entity 1385 1402	number of cancers
A8	Effect_Type E13 Decrease
R26	Effect_type_marker Arg1:E13 Arg2:T43	
R27	Member Arg1:T47 Arg2:T32	
T48	Neg 1444 1448	loss
T49	Other_effect 1479 1490	tumor grade
E14	Other_effect:T49 Agent:T45
R28	Negation_marker Arg1:E14 Arg2:T48	
T50	Level 1131 1137	higher
A9	Level E11 High
R29	Level_marker Arg1:E11 Arg2:T50	
T51	Level 1472 1478	higher
R30	Level_marker Arg1:E14 Arg2:T51	
A10	Level E14 High
T52	Patho_physiology 1495 1514	proliferation index
E15	Patho_physiology:T52 Agent:T45
A11	Level E15 High
R31	Level_marker Arg1:E15 Arg2:T51	
T53	Entity 1623 1625	GG
T54	SNP 1638 1648	rs13281615
R32	Genotype Arg1:T54 Arg2:T53	
R33	Equiv Arg1:T54 Arg2:T31	
T55	SNP 991 1001	rs13281615
R34	Equiv Arg1:T45 Arg2:T55	
A12	SNP_Type T55 Non-Coding
A13	SNP_Type T54 Non-Coding
R35	Population_assignment Arg1:T55 Arg2:T28	
R36	SNP_location Arg1:T55 Arg2:T11	
T56	Gene_Regulation 1545 1555	expression
E16	Gene_Regulation:T56 Theme:T58 Agent:T54
T57	Effect_Type 1560 1569	increased
R37	Effect_type_marker Arg1:E16 Arg2:T57	
A14	Effect_Type E16 Increase
T58	Entity 1540 1544	PVT1
T59	Entity 1681 1683	GG
T60	SNP 1700 1710	rs13281615
R38	SNP_coupled_gene Arg1:T60 Arg2:T59	
A15	SNP_Type T60 Non-Coding
R39	Equiv Arg1:T60 Arg2:T54	
T61	Spec 1664 1671	suggest
T62	Association 1719 1723	role
E17	Association:T62 bc:T63 snp_int:T60
R40	Speculation_marker Arg1:E17 Arg2:T61	
T63	Cancer 1727 1740	breast cancer
T64	Gene_Regulation 1768 1778	expression
E18	Gene_Regulation:T64 Theme:T65 Agent:T60
T65	Entity 1763 1767	PVT1
T66	Protective_effect 1810 1820	protective
E19	Protective_effect:T66 Theme:T67 Agent:T45
T67	Entity 1796 1807	oncogenesis
